首页> 外国专利> USE OF ALFA-D-GALACTOSIDASE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE REDUCTION OF GASTROINTESTINAL DISEASE PRODUCED BY UNITED SUGARS BY MEANS OF AN ALFA-D-GALACTOSIDE LINK.

USE OF ALFA-D-GALACTOSIDASE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE REDUCTION OF GASTROINTESTINAL DISEASE PRODUCED BY UNITED SUGARS BY MEANS OF AN ALFA-D-GALACTOSIDE LINK.

机译:α-D-半乳糖苷酶在制备药物组合物中的用途,所述药物组合物通过α-D-半乳糖苷链接的方式减少由联合糖产生的胃肠道疾病。

摘要

A COMPOSITE IS PROVIDED TO BE INGESTED BY THE MAMMALS FOR A LIVE CONVERSION OF THE ALFA-D-GALACTOSIDE THAT INCLUDES AN AMOUNT OF EFFECTIVE ALFA-GALACTOSIDE TO HYDROLIZE THE ALFA-D-GALACTOSIDE IN D-GALACTOSE (S) NON-TOXIC INGERABLE FOR SUCH ALFA-GALACTOSIDE. THE GASTRIC PAIN IN THE MAMMALS DUE TO THE INGESTION OF MEALS CONTAINING ALFA-D-GALACTOSIDE, MAY BE REDUCED BY INGESTING THE ALFA-GALACTOSIDASE COMPOUND AND EXCIPIENT INGERIBLE NON-TOXIC, TOGETHER WITH THE EFFECTIVENESS OF THE COMMUNITY ALFA-D-GALACTOSE IN D-GALACTOSE.
机译:哺乳动物必须摄取一种复合物才能进行阿尔法-D-半乳糖苷的实时转化,其中包括大量有效的阿尔法-半乳糖苷水解成D-半乳糖(S)非毒性不可侵犯的Alfa-D-半乳糖苷这类半乳糖苷。由于食用阿尔法-D-半乳糖苷的食物而引起的哺乳动物的胃痛,可以通过摄取阿尔法-半乳糖苷酶化合物和优良的不可侵犯的非毒性物质来减少,同时还要考虑到社区中阿尔法-谷胱甘肽的有效性。 -半乳糖。

著录项

  • 公开/公告号ES2084696T5

    专利类型

  • 公开/公告日2002-08-16

    原文格式PDF

  • 申请/专利权人 BLOCK DRUG COMPANY INC.;

    申请/专利号ES19900907625T

  • 发明设计人 KLIGERMAN ALAN E.;

    申请日1990-05-10

  • 分类号A23L1/03;A61K38/47;

  • 国家 ES

  • 入库时间 2022-08-22 00:41:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号